Table 6.
Treatment during the present admission
| Item | Frequency out of 16 (%) |
|---|---|
| Drugs for Myasthenia gravis | |
| Anti-cholinesterase (pyridostigmine - 8, neostigmine - 5, unidentified drug - 2) | 15 (94) |
| Corticosteroids (prednisolone - 8, hydrocortisone - 1, methylprednisolone - 1) | 10 (63) |
| Intravenous immunoglobulin | 4 (25) |
| Immunosuppressants (mycophenolate mofetil - 1, unidentified drug - 1) | 2 (13) |
| Drugs for Takotsubo syndrome | |
| Dobutamine | 5 (31) |
| Noradrenaline | 2 (13) |
| Angiotensin-converting enzyme (drug unidentified) | 1 (6) |
| Bisoprolol | 1 (6) |
| Diuretics (drug unidentified) | 1 (6) |
| Dopamine | 1 (6) |
| Enalapril | 1 (6) |
| Levosimendan | 1 (6) |
| Ramipril | 1 (6) |
| Treatment on discharge | |
| Prednisolone | 6 (38) |
| Pyridostigmine | 3 (19) |
| Azathioprine | 1 (6) |
| Intravenous immunoglobulin | 1 (6) |
| Mycophenolate mofetil | 1 (6) |
| Neostigmine | 1 (6) |
| Plasmapheresis | 1 (6) |
| Radiation | 1 (6) |